Newgenpharm to acquire license for cancer gene therapy.

Published: 2006-01-23 07:00:00

Updated: 2006-01-23 07:00:00

Newgenpharm announced to acquire "Celagen" an anti-cancer gene therapy from Henry Ford hospital in the United States, which was scheduled to commercialize until 2008.

Dr. Kim Jae-ho and colleagues of Henry Ford hospital made a technology transfer to Newgenpharm at Sogongdong Lotte hotel, Seoul...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK